A research study conducted at QIMR Berghofer Medical Research Institute in Queensland, Australia has claimed that the australian blushwood fruit could be used for the cancer treatment. The Australian berry is said to be loaded with cancer-killing compounds that can show instant affect.
The QIMR Berghofer Medical Research Institute stated that the Scientists have managed to destroy cancerous tumors by using the drug extracted from the Australian blushwood fruit seeds which are majorly found in the Queensland rainforests.
The drug named EBC-46 has been extracted from the berry of the blushwood tree, and a single injection of the drug directly into melanoma models as well as into cancers of the head, neck and colon in animals is found to have destroyed the tumors long-term in more than 70% of cases, say Dr Glen Boyle
Boyle from the QIMR Berghofer Medical Research Institute stated, “In preclinical trials we injected it into our models and within five minutes, you see a purpling of the area that looks like a bruise.”
He further added, “About 24 hours later, the tumour area goes black, a couple of days later you see a scab, and at around the 1.5 week mark, the scab falls off, leaving clean skin with no tumour there. The speed certainly surprised me.”
Scientists observed that this drug EBC-46 has the potential to trigger the cellular response which halts the blood supply to the tumor by opening it up. It is the reason for the bruise-like formation in tumour. “This seems to lead to an activation of the body’s own immune system which then comes in and cleans up the mess,” Boyle added
Veterinarians have already used this Blushwood tree cancer cure in about 300 cases of cancer in companion animals among dogs, cats and horses. However, there are no findings that EBC-46 would be useful to treat cancers that had spread to other parts of the body, known as metastatic cancers, said Boyle. It is found that the tumors reacted by turning a dark color, then falling off. This australian blushwood extract berry is thought to cut off oxygen supply to the cancer cells, allowing for the removal of tumors without the need for surgery, chemotherapy or radiation therapy.
Presently the drug is being used as human and veterinary pharmaceutical through QBiotics, which is the subsidiary of the company which discovered the drug, called EcoBiotics.
“Chemotherapy is still used because it is very effective for a lot of people. But EBC-46 could perhaps be used in people who, for some reason, chemotherapy doesn’t work [for], or for elderly patients whose body can’t sustain another round of chemotherapy treatment,” Boyle said.
QIMR Berghofer and the National Health and Medical Research Council funded for the preclinical trial and the results were published in the journal PLOS One.
*Results may vary from person to person and results are not guaranteed